Michael D. Kaytor

3.2k total citations · 1 hit paper
37 papers, 2.6k citations indexed

About

Michael D. Kaytor is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michael D. Kaytor has authored 37 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michael D. Kaytor's work include Effects of Radiation Exposure (16 papers), Genetic Neurodegenerative Diseases (10 papers) and DNA Repair Mechanisms (8 papers). Michael D. Kaytor is often cited by papers focused on Effects of Radiation Exposure (16 papers), Genetic Neurodegenerative Diseases (10 papers) and DNA Repair Mechanisms (8 papers). Michael D. Kaytor collaborates with scholars based in United States, Canada and Greece. Michael D. Kaytor's co-authors include Harry T. Orr, Huda Y. Zoghbi, H. Brent Clark, Pamela J. Skinner, Ivan A. Klement, Hong Yi, Lisa Duvick, Stephen T. Warren, Tao Zu and Hung-Kai Chen and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Neuron.

In The Last Decade

Michael D. Kaytor

37 papers receiving 2.5k citations

Hit Papers

Ataxin-1 Nuclear Localization and Aggregation 1998 2026 2007 2016 1998 250 500 750

Peers

Michael D. Kaytor
Diana Casper United States
Sandra Redeker Netherlands
Mark A. Pook United Kingdom
Kambiz N. Alavian United States
Yang Yuan United States
Brent J. Ryan United Kingdom
Michael D. Kaytor
Citations per year, relative to Michael D. Kaytor Michael D. Kaytor (= 1×) peers Jan Christoph Koch

Countries citing papers authored by Michael D. Kaytor

Since Specialization
Citations

This map shows the geographic impact of Michael D. Kaytor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Kaytor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Kaytor more than expected).

Fields of papers citing papers by Michael D. Kaytor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Kaytor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Kaytor. The network helps show where Michael D. Kaytor may publish in the future.

Co-authorship network of co-authors of Michael D. Kaytor

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Kaytor. A scholar is included among the top collaborators of Michael D. Kaytor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Kaytor. Michael D. Kaytor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fatanmi, Oluseyi O., Stephen Y. Wise, Cara Olsen, et al.. (2025). Lethality Assessments for Acutely Irradiated Cynomolgus Macaques Under Subject-based Care. Radiation Research. 203(5). 304–320. 1 indexed citations
2.
Singh, Vijay K., et al.. (2024). BIO 300: A Prophylactic Radiation Countermeasure for Acute Radiation Syndrome. Military Medicine. 189(Supplement_3). 390–398. 4 indexed citations
3.
Serebrenik, Artur A., et al.. (2024). BIO 300 Attenuates Whole Blood Transcriptome Changes in Mice Exposed to Total-Body Radiation. International Journal of Molecular Sciences. 25(16). 8818–8818. 1 indexed citations
4.
Simone, Charles B., Artur A. Serebrenik, Elizabeth Gore, et al.. (2023). Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients With Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy. International Journal of Radiation Oncology*Biology*Physics. 118(2). 404–414. 9 indexed citations
5.
Singh, Vijay K., et al.. (2023). The Radioprotectant, BIO 300, Protects the Lungs from Total-Body Irradiation Injury in C57L/J Mice. Radiation Research. 199(3). 294–300. 15 indexed citations
6.
Li, Yaoxiang, Michael Girgis, Artur A. Serebrenik, et al.. (2022). Pharmacokinetic and metabolomic studies with a BIO 300 Oral Powder formulation in nonhuman primates. Scientific Reports. 12(1). 13475–13475. 16 indexed citations
7.
Cheema, Amrita K., Yaoxiang Li, Ryan C. Johnson, et al.. (2021). Microbiome study in irradiated mice treated with BIO 300, a promising radiation countermeasure. SHILAP Revista de lepidopterología. 3(1). 71–71. 22 indexed citations
8.
Jackson, Isabel L., Diana Newman, Javed Mahmood, et al.. (2019). BIO 300, a Nanosuspension of Genistein, Mitigates Radiation-Induced Erectile Dysfunction and Sensitizes Human Prostate Cancer Xenografts to Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 105(2). 400–409. 21 indexed citations
9.
Mahmood, Javed, et al.. (2017). Treatment With Nano-Genistein for the Prevention of Radiation-Induced Erectile Dysfunction. International Journal of Radiation Oncology*Biology*Physics. 99(2). E622–E623. 2 indexed citations
10.
Jones, Jace W., Isabel L. Jackson, Željko Vujašković, Michael D. Kaytor, & Maureen A. Kane. (2017). Targeted Metabolomics Identifies Pharmacodynamic Biomarkers for BIO 300 Mitigation of Radiation-Induced Lung Injury. Pharmaceutical Research. 34(12). 2698–2709. 25 indexed citations
11.
Kaytor, Michael D., et al.. (2005). A cell-based screen for modulators of ataxin-1 phosphorylation. Human Molecular Genetics. 14(8). 1095–1105. 22 indexed citations
12.
Kaytor, Michael D., Keith D. Wilkinson, & Stephen T. Warren. (2004). Modulating huntingtin half‐life alters polyglutamine‐dependent aggregate formation and cell toxicity. Journal of Neurochemistry. 89(4). 962–973. 31 indexed citations
13.
Chen, Hung-Kai, Pedro Fernández-Fúnez, Summer F. Acevedo, et al.. (2003). Interaction of Akt-Phosphorylated Ataxin-1 with 14-3-3 Mediates Neurodegeneration in Spinocerebellar Ataxia Type 1. Cell. 113(4). 457–468. 333 indexed citations
14.
Emamian, Effat S., Michael D. Kaytor, Lisa Duvick, et al.. (2003). Serine 776 of Ataxin-1 Is Critical for Polyglutamine-Induced Disease in SCA1 Transgenic Mice. Neuron. 38(3). 375–387. 235 indexed citations
15.
Kaytor, Michael D.. (2002). The GSK3β signaling cascade and neurodegenerative disease. Current Opinion in Neurobiology. 12(3). 275–278. 178 indexed citations
16.
Kaytor, Michael D., Lisa Duvick, Pamela J. Skinner, et al.. (1999). Nuclear Localization of the Spinocerebellar Ataxia Type 7 Protein, Ataxin-7. Human Molecular Genetics. 8(9). 1657–1664. 78 indexed citations
17.
Kaytor, Michael D., Eric N. Burright, Lisa Duvick, Huda Y. Zoghbi, & Harry T. Orr. (1997). Increased Trinucleotide Repeat Instability with Advanced Maternal Age. Human Molecular Genetics. 6(12). 2135–2139. 76 indexed citations
18.
Kaytor, Michael D. & Dennis Livingston. (1996). Allele-specific suppression of temperature-sensitive mutations of theSaccharomyces cerevisiae RAD52 gene. Current Genetics. 29(3). 203–210. 10 indexed citations
19.
Kaytor, Michael D. & Dennis Livingston. (1995). GSG1, a yeast gene required for sporulation. Yeast. 11(12). 1147–1155. 12 indexed citations
20.
Kaytor, Michael D. & Dennis Livingston. (1994). Saccharomyces cerevisiae RAD52 alleles temperature-sensitive for the repair of DNA double-strand breaks.. Genetics. 137(4). 933–944. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026